Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
3,430
datasets available to search
ShareScore release 0.9.0
Dataset results
3,430 results for “PD”
A Study of the PD-L1xCD27 Bispecific Antibody CDX-527 in Patients With Advanced Malignancies
ClinicalTrials.gov study NCT04440943. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Phase II Study of Anti-PD-1/VEGF Bispecific Antibody Ivonescimab in Patients With Previously Treated Metastatic Colorectal Cancer
ClinicalTrials.gov study NCT06959550. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Evaluate the Efficacy of Pumitamig Versus Pembrolizumab in Participants With Previously Untreated Advanced Non-Small Cell Lung Cancer and PD-L1 ≥ 50%. (ROSETTA Lung-202)
ClinicalTrials.gov study NCT07361510. IPD Sharing: YES. Countries: 36. Publications: 0.
Neoadjuvant Toripalimab for Clinically Stage II-IIIB Resectable Non-small Cell Lung Cancer with EGFR Mutation and PD-L1 Positive Expression
ClinicalTrials.gov study NCT06269211. IPD Sharing: NO. Countries: 1. Publications: 0.
Clinical Study of Neoadjuvant PD-1 Antibody (Toripalimab) Plus Chemotherapy for Locally Advanced Thymic Epithelial Tumor
ClinicalTrials.gov study NCT04667793. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Safety, Tolerability, PK, and PD of LIM-0705 in Subjects With Impaired Glucose Tolerance or Abnormal HOMA-IR
ClinicalTrials.gov study NCT01364155. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of ES101 (PD-L1x4-1BB Bispecific Antibody) in Patients With Advanced Solid Tumors
ClinicalTrials.gov study NCT04009460. IPD Sharing: NO. Countries: 1. Publications: 0.
Study of CDK4/6 Inhibitor Combined With PD-L1 Monoclonal Antibody in the Treatment of PD-1/PD-L1 Resistance and Abnormal Cell Cycle Digestive System Tumors
ClinicalTrials.gov study NCT05139082. IPD Sharing: NO. Countries: 1. Publications: 0.
SABR Combined With Targeted Therapy and Anti-PD-1 for Recurrent or Metastatic Renal Cancer
ClinicalTrials.gov study NCT06583070. IPD Sharing: Not stated. Countries: 1. Publications: 0.
PD-L1 Expression in Japanese Renal Cell Carcinoma Patients
ClinicalTrials.gov study NCT03748901. IPD Sharing: YES. Countries: 1. Publications: 0.
PD-1 Blockade and Bevacizumab Replace Cisplatin in Locoregionally Advanced Nasopharyngeal Carcinoma
ClinicalTrials.gov study NCT05341193. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Multiple Dose Safety, Tolerability, PK，PD and Food Effect Study of HEC96719 in Healthy Adult Subjects
ClinicalTrials.gov study NCT04546984. IPD Sharing: NO. Countries: 1. Publications: 0.
Short-course Radiotherapy Followed by Sequential Chemotherapy With or Without PD-1 Monoclonal Antibody and Bevacizumab as Total Neoadjuvant Therapy in pMMR/MSS Locally Advanced Rectal Cancer （SPARK）
ClinicalTrials.gov study NCT07005570. IPD Sharing: NO. Countries: 1. Publications: 0.
Multi-center Observational Study on the Progression of Atherosclerotic Plaques in Anti-PD-1 mAb Treated Tumor Patients by Artery Ultrasound Follow-up
ClinicalTrials.gov study NCT04922541. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Treatment of PD-1 Inhibitor in AIDS-associated PML
ClinicalTrials.gov study NCT04091932. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study to Investigate the Safety, Tolerability, PK, PD, and Efficacy of ONO-7018 in Patients With R/R NHL or CLL
ClinicalTrials.gov study NCT05515406. IPD Sharing: NO. Countries: 1. Publications: 0.
SBRT and Anti-programmed Cell Death Protein 1(Anti-PD-1) in Late Stage or Recurrent Pancreatic Cancer Patients
ClinicalTrials.gov study NCT03716596. IPD Sharing: UNDECIDED. Countries: 1. Publications: 0.
Golidocitinib With PD-1 Inhibitors as Maintenance Treatment for Previously Untreated ES-SCLC
ClinicalTrials.gov study NCT07110103. IPD Sharing: NO. Countries: 1. Publications: 0.
PD-1 + FOLFOXIRI vs CAPOX as Total Neoadjuvant Therapy for pMMR Low Rectal Cancer
ClinicalTrials.gov study NCT07277842. IPD Sharing: NO. Countries: 1. Publications: 0.
A Study to Evaluate the Safety, PK and PD of VIS171 in Participants (Healthy and with Autoimmune Disease)
ClinicalTrials.gov study NCT05418101. IPD Sharing: NO. Countries: 5. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.